AccuBio AccuBio
AccuBio
Products AccuBio VISITECT® CD4 Advanced Disease AccuBio VISITECT®  CD4 Advanced Disease
AccuBio
AccuBio

CD4 is an important measure of disease progression and immune status in HIV.

If a person's CD4 level is below 200 they have advanced HIV disease (WHO guidelines, 2017).

VISITECT® CD4 Advanced Disease is a unique rapid test supporting the identification of advanced HIV disease.

VISITECT® CD4 Advanced Disease is easily implemented in decentralised settings.

  • AccuBio
    Results in 40 minutes
  • AccuBio
    Fingerstick or venous blood
  • AccuBio
    CE mark WHO Prequalified
  • AccuBio
    18 months shelf-life
  • AccuBio
    2-30°C storage
VISITECT® Advanced Disease test is intended as an aid to support the identification of Advanced HIV Disease (AHD) in pre-diagnosed HIV patients. Tests results should be considered in conjunction with all clinical data to inform patient management.
  • AccuBio
    Reduce patient loss to follow-up
    Improve patient retention.
  • AccuBio
    Test anywhere, anytime
    Convenient, disposable and read by eye.
  • AccuBio
    Reduce costs
    No equipment or sample transport needed. More affordable than flow cytometry.
  • AccuBio
    Improve patient outcomes
    Patients with advanced HIV disease identi-fied earlier.
AccuBio
AccuBio